Back to Search Start Over

A proposed scheme to cope with comorbidities in asthma.

Authors :
Marques de Mello, Luane
Cruz, Álvaro A.
Source :
Pulmonary Pharmacology & Therapeutics. Oct2018, Vol. 52, p41-51. 11p.
Publication Year :
2018

Abstract

Abstract The prevalence of non-communicable chronic diseases has been on the rise and the co-occurrence of morbidities is becoming more common. Multimorbidities are found more frequently among women, those with a history of mental disorders, lower level of schooling, and unfavorable socioeconomic condition. Physical inactivity, smoking and obesity are also associated with multimorbidities. Its occurrence is directly related to the age, affecting the majority of the individuals with more than 50 years old. It is important to consider the possibility of comorbid conditions that aggravate, complicate or simulate the symptoms of the disease in the face of a patient with asthma and poor response to treatment. Among subjects with asthma, some conditions stand out as the most frequent: chronic rhinitis or rhinosinusitis, gastroesophageal reflux disease, obstructive sleep apnea syndrome, obesity, and cardiovascular disorders. Comorbidities reduce the chances of optimal asthma control. It is essential to assess and manage properly these complex situations, choosing wisely preventive strategies and treatment options to avoid adverse events and optimize outcomes. Medications for asthma have the potential to worsen cardiovascular conditions, while beta-adrenergic receptor blockers and angiotensin conversion enzyme inhibitors used for cardiovascular conditions, can worsen asthma. Handling properly these cases will save lives and resources. However, there are multiple gaps in knowledge requiring investigation in this field to inform integrated care pathways and policies. It is likely information may be obtained from real life studies and electronic medical databases. Communications between the providers and patients may be facilitated by electronic technology, opening a large window for guided self-management. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
10945539
Volume :
52
Database :
Academic Search Index
Journal :
Pulmonary Pharmacology & Therapeutics
Publication Type :
Academic Journal
Accession number :
131807211
Full Text :
https://doi.org/10.1016/j.pupt.2018.08.005